Top Glove Corporation - the DBS Vickers Securities Equities Research

Top Glove Corporation - the DBS Vickers Securities Equities Research Top Glove Corporation - the DBS Vickers Securities Equities Research

dbsvresearch.com
from dbsvresearch.com More from this publisher

Company Focus<strong>Top</strong> <strong>Glove</strong> <strong>Corporation</strong>HighlightHigher selling prices offsets increases in latex cost. Latexprices have risen 24% since 1 Sep09 (<strong>the</strong> start of <strong>Top</strong><strong>Glove</strong>’s 2010 financial year). In <strong>the</strong> Sep-Nov09 quarter,latex prices jumped 19% q-o-q. We estimate every 1%increase in latex cost reduces FY10F net earnings by 3%,while every 1% appreciation of <strong>the</strong> RM against <strong>the</strong> USDreduces FY10F earnings by 4.3%. But <strong>the</strong> fluctuations inlatex prices and forex rates were mitigated by revisions toselling prices. We understand that <strong>Top</strong> <strong>Glove</strong> revised its ASPin Oct and Nov 09 following <strong>the</strong> increase in latex prices anda stronger Ringgit. Looking at <strong>the</strong> EBITDA margin trend in<strong>the</strong> previous quarters, <strong>Top</strong> <strong>Glove</strong>’s cost pass-throughmechanism seems to be effective. FY10F EBITDA marginshould be close to <strong>the</strong> 18.7% achieved in FY09A.Latex Price TrendLatex price (sen/kg)800700600500400300200100Jan-05Mar-05May-05Jul-05Sep-05Nov-05Jan-06Mar-06May-06Jul-06Sep-06Nov-06Jan-07Mar-07May-07Jul-07Sep-07Nov-07Jan-08Mar-08May-08Jul-08Sep-08Nov-08Jan-09Mar-09May-09Jul-09Sep-09Nov-09Source: Bloomberg, <strong>DBS</strong> <strong>Vickers</strong>Latex PriceQuarterly average: Latex price vs EBITDA marginsen/kg %Currency Trend: USD vs RMRM3.803.603.403.203.00Jan-08Mar-08May-08Jul-08Sep-08Source: Bloomberg, <strong>DBS</strong> <strong>Vickers</strong>Nov-08Jan-09USDMYR CurncyMar-09May-09Quarterly average: USD/RM vs EBITDA marginJul-09Sep-09Nov-09RM %3.90253.803.70203.60153.503.40103.3053.203.10-1Q062Q063Q064Q061Q072Q073Q074Q071Q082Q083Q084Q081Q092Q093Q094Q091Q10USD/MYREBITDA marginSource: Bloomberg, <strong>DBS</strong> <strong>Vickers</strong>, CompanyMediflex turned around. Mediflex, which was loss makingin FY09, is in a stronger position in FY10 following <strong>the</strong>conversion of some of its clean room gloves productionlines to manufacture medical gloves. Capacity utilizationincreased to 80% as a result.7006002520Valuation500400300200100-1Q062Q063Q064Q061Q072Q073Q074Q071Q082Q083Q084Q081Q092Q09Average latex price EBITDA marginSource: Bloomberg, <strong>DBS</strong> <strong>Vickers</strong>, Company3Q094Q091Q1015105-Our target multiple is based on 15x CY10 EPS. This is belowits high of between 20-25x registered in FY06 -07 that waslifted by expectations of high net profit growth (FY04-07net profit CAGR of 38%). But this subsequently fell (FY08growth was 6%). We believe 15x PE is fair given ourexpectation of more modest growth rate in <strong>the</strong> next threeyears (13% CAGR over FY09-12F).Page 2


Company Focus<strong>Top</strong> <strong>Glove</strong> <strong>Corporation</strong><strong>DBS</strong>V recommendations are based an Absolute Total Return* Rating system, defined as follows:STRONG BUY (>20% total return over <strong>the</strong> next 3 months, with identifiable share price catalysts within this time frame)BUY (>15% total return over <strong>the</strong> next 12 months for small caps, >10% for large caps)HOLD (-10% to +15% total return over <strong>the</strong> next 12 months for small caps, -10% to +10% for large caps)FULLY VALUED (negative total return i.e. > -10% over <strong>the</strong> next 12 months)SELL (negative total return of > -20% over <strong>the</strong> next 3 months, with identifiable catalysts within this time frame)Share price appreciation + dividends<strong>DBS</strong> <strong>Vickers</strong> <strong>Research</strong> is available on <strong>the</strong> following electronic platforms: <strong>DBS</strong> <strong>Vickers</strong> (www.dbsvresearch.com); Thomson(www.thomson.com/financial); Factset (www.factset.com); Reuters (www.rbr.reuters.com); Capital IQ (www.capitaliq.com) and Bloomberg(<strong>DBS</strong>R GO). For access, please contact your <strong>DBS</strong>V salesperson.GENERAL DISCLOSURE/DISCLAIMERThis document is published by <strong>DBS</strong> <strong>Vickers</strong> <strong>Research</strong> (Singapore) Pte Ltd ("<strong>DBS</strong>VR"), a direct wholly-owned subsidiary of <strong>DBS</strong> <strong>Vickers</strong><strong>Securities</strong> (Singapore) Pte Ltd ("<strong>DBS</strong>VS") and an indirect wholly-owned subsidiary of <strong>DBS</strong> <strong>Vickers</strong> <strong>Securities</strong> Holdings Pte Ltd ("<strong>DBS</strong>VH").[This report is intended for clients of <strong>DBS</strong>V Group only and no part of this document may be (i) copied, photocopied or duplicated in anyform by any means or (ii) redistributed without <strong>the</strong> prior written consent of <strong>DBS</strong>VR.]The research is based on information obtained from sources believed to be reliable, but we do not make any representation or warranty asto its accuracy, completeness or correctness. Opinions expressed are subject to change without notice. This document is prepared forgeneral circulation. Any recommendation contained in this document does not have regard to <strong>the</strong> specific investment objectives, financialsituation and <strong>the</strong> particular needs of any specific addressee. This document is for <strong>the</strong> information of addressees only and is not to be takenin substitution for <strong>the</strong> exercise of judgement by addressees, who should obtain separate legal or financial advice. <strong>DBS</strong>VR accepts no liabilitywhatsoever for any direct or consequential loss arising from any use of this document or fur<strong>the</strong>r communication given in relation to thisdocument. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. <strong>DBS</strong>VH is a whollyownedsubsidiary of <strong>DBS</strong> Bank Ltd. <strong>DBS</strong> Bank Ltd along with its affiliates and/or persons associated with any of <strong>the</strong>m may from time totime have interests in <strong>the</strong> securities mentioned in this document. <strong>DBS</strong>VR, <strong>DBS</strong>VS, <strong>DBS</strong> Bank Ltd and <strong>the</strong>ir associates, <strong>the</strong>ir directors, and/oremployees may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to performbroking, investment banking and o<strong>the</strong>r banking services for <strong>the</strong>se companies.The assumptions for commodities in this report are for <strong>the</strong> purpose of forecasting earnings of <strong>the</strong> companies mentioned herein. They arenot to be construed as recommendations to trade in <strong>the</strong> physical commodities or in futures contracts relating to <strong>the</strong> commoditiesmentioned in this report.<strong>DBS</strong>VUSA does not have its own investment banking or research department, nor has it participated in any investment banking transactionas a manager or co-manager in <strong>the</strong> past twelve months. Any US persons wishing to obtain fur<strong>the</strong>r information, including any clarificationon disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact <strong>DBS</strong>VUSA exclusively.ANALYST CERTIFICATIONThe research analyst primarily responsible for <strong>the</strong> content of this research report, in part or in whole, certifies that <strong>the</strong> views about <strong>the</strong>companies and <strong>the</strong>ir securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part ofhis/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report. As of15 Dec 2009, <strong>the</strong> analyst and his / her spouse and/or relatives who are financially dependent on <strong>the</strong> analyst, do not hold interests in <strong>the</strong>securities recommended in this report (“interest” includes direct or indirect ownership of securities, directorships and trustee positions).COMPANY-SPECIFIC / REGULATORY DISCLOSURES1. <strong>DBS</strong> <strong>Vickers</strong> <strong>Securities</strong> (Singapore) Pte Ltd and its subsidiaries do not have a proprietary position in <strong>the</strong> mentionedcompany as of 11-Dec-20092. <strong>DBS</strong>VR, <strong>DBS</strong>VS, <strong>DBS</strong> Bank Ltd and/or o<strong>the</strong>r affiliates of <strong>DBS</strong> <strong>Vickers</strong> <strong>Securities</strong> (USA) Inc ("<strong>DBS</strong>VUSA"), a U.S.-registeredbroker-dealer, may beneficially own a total of 1% or more of any class of common equity securities of <strong>the</strong> mentionedcompany as of 15 Dec 2009.3. Compensation for investment banking services:i. <strong>DBS</strong>VR, <strong>DBS</strong>VS, <strong>DBS</strong> Bank Ltd and/or o<strong>the</strong>r affiliates of <strong>DBS</strong>VUSA may have received compensation, within <strong>the</strong> past12 months, and within <strong>the</strong> next 3 months receive or intends to seek compensation for investment banking servicesfrom <strong>the</strong> mentioned company.ii. <strong>DBS</strong>VUSA does not have its own investment banking or research department, nor has it participated in anyinvestment banking transaction as a manager or co-manager in <strong>the</strong> past twelve months. Any US persons wishing toobtain fur<strong>the</strong>r information, including any clarification on disclosures in this disclaimer, or to effect a transaction inany security discussed in this document should contact <strong>DBS</strong>VUSA exclusively.Page 5


Company Focus<strong>Top</strong> <strong>Glove</strong> <strong>Corporation</strong>RESTRICTIONS ON DISTRIBUTIONGeneralThis report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen orresident of or located in any locality, state, country or o<strong>the</strong>r jurisdiction where such distribution, publication,availability or use would be contrary to law or regulation.AustraliaHong KongSingaporeUnited KingdomDubai/United Arab EmiratesUnited StatesO<strong>the</strong>r jurisdictionsThis report is being distributed in Australia by <strong>DBS</strong>VR and <strong>DBS</strong>VS, which are exempted from <strong>the</strong> requirement tohold an Australian financial services licence under <strong>the</strong> <strong>Corporation</strong> Act 2001 [“CA] in respect of financial servicesprovided to <strong>the</strong> recipients. <strong>DBS</strong>VR and <strong>DBS</strong>VS are regulated by <strong>the</strong> Monetary Authority of Singapore [“MAS”]under <strong>the</strong> laws of Singapore, which differ from Australian laws. Distribution of this report is intended only for“wholesale investors” within <strong>the</strong> meaning of <strong>the</strong> CA.This report is being distributed in Hong Kong by <strong>DBS</strong> <strong>Vickers</strong> (Hong Kong) Limited which is licensed andregulated by <strong>the</strong> Hong Kong <strong>Securities</strong> and Futures Commission.This report is being distributed in Singapore by <strong>DBS</strong>VR, which holds a Financial Adviser’s licence and is regulatedby <strong>the</strong> MAS. This report may additionally be distributed in Singapore by <strong>DBS</strong>VS (Company Regn. No.198600294G), which is an Exempt Financial Adviser as defined under <strong>the</strong> Financial Advisers Act. Any researchreport produced by a foreign <strong>DBS</strong> <strong>Vickers</strong> entity, analyst or affiliate is distributed in Singapore only to“Institutional Investors”, “Expert Investors” or “Accredited Investors” as defined in <strong>the</strong> <strong>Securities</strong> and FuturesAct, Chap. 289 of Singapore. Any distribution of research reports published by a foreign-related corporation of<strong>DBS</strong>VR/<strong>DBS</strong>VS to “Accredited Investors” is provided pursuant to <strong>the</strong> approval by MAS of research distributionarrangements under Paragraph 11 of <strong>the</strong> First Schedule to <strong>the</strong> FAA.This report is being distributed in <strong>the</strong> UK by <strong>DBS</strong> <strong>Vickers</strong> <strong>Securities</strong> (UK) Ltd, who is an authorised person in <strong>the</strong>meaning of <strong>the</strong> Financial Services and Markets Act and is regulated by The Financial Services Authority. <strong>Research</strong>distributed in <strong>the</strong> UK is intended only for institutional clients.This report is being distributed in Dubai/United Arab Emirates by <strong>DBS</strong> Bank Ltd, Dubai (PO Box 506538, 3 rd Floor,Building 3, Gate Precinct, DIFC, Dubai, United Arab Emirates) and is intended only for clients who meet <strong>the</strong>DFSA regulatory criteria to be a Professional Client. It should not be relied upon by or distributed to RetailClients. <strong>DBS</strong> Bank Ltd, Dubai is regulated by <strong>the</strong> Dubai Financial Services Authority.Nei<strong>the</strong>r this report nor any copy hereof may be taken or distributed into <strong>the</strong> United States or to any U.S. personexcept in compliance with any applicable U.S. laws and regulations.In any o<strong>the</strong>r jurisdictions, except if o<strong>the</strong>rwise restricted by laws or regulations, this report is intended only forqualified, professional, institutional or sophisticated investors as defined in <strong>the</strong> laws and regulations of suchjurisdictions.<strong>DBS</strong> <strong>Vickers</strong> <strong>Research</strong> (Singapore) Pte Ltd – 8 Cross Street, #02-01 PWC Building, Singapore 048424Tel. 65-6533 9688, Fax: 65-6226 8048Company Regn. No. 198600295WPage 6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!